Trinity Biotech PLC
TRIB- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000888721
No open-market purchases or sales by Trinity Biotech PLC insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $388.5K in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −2 vs. previous quarter
- 20
- 13F valueReported value at the end of Q2 2026
- $388.5K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding TRIB, Q2 2026
No superinvestor reported holding TRIB at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Trinity Biotech PLC insiders from Form 4, newest first.
No open-market purchases or sales by Trinity Biotech PLC insiders are on file.
Top 10 13F holders, Q2 2026
The largest institutional positions in Trinity Biotech PLC at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Hunter Associates Investment Management LLC | 661,210 | $251.0K | 0.03% | +125,000+23.3% | Added |
| Williams & Novak, LLC | 140,543 | $54.6K | 0.04% | +32,900+30.6% | Added |
| Cambridge Investment Research Advisors, Inc. | 44,560 | $18.0K | 0.00% | +22,280+100.0% | Added |
| Susquehanna International Group, LLP | 26,859 | $10.4K | 0.00% | +26,859 | New |
| Moss Adams Wealth Advisors LLC | 25,666 | $9.98K | 0.00% | 00.0% | Unchanged |
| Inspirion Wealth Advisors, LLC | 25,000 | $8.92K | 0.00% | 00.0% | Unchanged |
| Raymond James Financial Inc | 20,319 | $7.90K | 0.00% | 00.0% | Unchanged |
| Becker Capital Management Inc | 18,000 | $7.00K | 0.00% | 00.0% | Unchanged |
| LPL Financial LLC | 17,668 | $6.87K | 0.00% | +2,632+17.5% | Added |
| Geode Capital Management, LLC | 12,598 | $4.90K | 0.00% | −4,044−24.3% | Reduced |